Standard BioTools Inc. (LAB)
NASDAQ: LAB
· Real-Time Price · USD
1.22
0.00 (0.00%)
At close: Aug 15, 2025, 12:12 PM
Standard BioTools Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 154.24M | 169.69M | 174.43M | 155.9M | 136.3M | 126.76M | 106.34M | 105.17M | 105.45M | 96.56M | 97.95M | 109.19M | 112.05M | 124.29M | 130.58M | 136.92M | 148.28M | 143.32M |
Cost of Revenue | 66.83M | 89.87M | 90.17M | 80.19M | 72.69M | 64.46M | 56.1M | 57.13M | 59.34M | 59.63M | 60.9M | 63.07M | 61.48M | 61.72M | 61.21M | 61.58M | 61.28M | 57.41M |
Gross Profit | 66.84M | 79.81M | 84.26M | 75.71M | 63.61M | 62.3M | 50.24M | 48.05M | 46.11M | 36.94M | 37.05M | 46.13M | 50.58M | 62.57M | 69.37M | 75.35M | 87M | 85.92M |
Operating Income | -117.2M | -148.02M | -175.24M | -157.32M | -146.78M | -113.71M | -70.12M | -76.33M | -84.18M | -105.3M | -116.2M | -106.35M | -96.94M | -75.64M | -67.46M | -73.1M | -58.96M | -55.41M |
Interest Income | 15.96M | 17.94M | 20.2M | 13.56M | 10.84M | 7.53M | 3.47M | 3.47M | 2.25M | 1.12M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -102.39M | -132.47M | -138.31M | -124.45M | -118.58M | -89.65M | -74.2M | -75.04M | -84.23M | -132.65M | -192.93M | -182.4M | -167.52M | -120.03M | -63.66M | -70.46M | -61.43M | -57.93M |
Net Income | -120.5M | -132.76M | -138.88M | -124.59M | -118.65M | -89.97M | -74.66M | -75.72M | -84.15M | -130.65M | -190.1M | -178.68M | -163.1M | -116.7M | -59.24M | -67.83M | -59.99M | -55.86M |
Selling & General & Admin | 129.92M | 148.37M | 156.61M | 140.37M | 128.26M | 113.19M | 88.55M | 91.1M | 98.41M | 106.19M | 114.76M | 113.82M | 108.29M | 102.16M | 98.89M | 107.86M | 106.45M | 102.81M |
Research & Development | 38.87M | 57.76M | 62.41M | 55.27M | 48.48M | 35.44M | 25.87M | 27.34M | 29.62M | 36.04M | 38.5M | 38.66M | 39.22M | 36.06M | 37.94M | 40.59M | 39.51M | 38.52M |
Other Expenses | 13.18M | 43.16M | 40.48M | 37.4M | 33.64M | 3.66M | 3.66M | 3.66M | -63K | -63K | 55K | 55K | 118K | 118K | -285K | -285K | -178K | -178K |
Operating Expenses | 181.97M | 249.29M | 259.5M | 233.04M | 210.39M | 152.3M | 118.09M | 122.11M | 128.03M | 142.23M | 153.26M | 152.48M | 147.51M | 138.21M | 136.83M | 148.45M | 145.95M | 141.33M |
Interest Expense | 3.33M | 3.32M | 4.35M | 2.13M | 3.35M | 4.48M | 4.57M | 4.66M | 4.49M | 4.42M | 4.33M | 4.21M | 4.13M | 3.97M | 3.82M | 3.64M | 3.56M | 3.56M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 275.45M | 317.71M | 349.67M | 319.71M | 289.56M | 244.68M | 180.67M | 179.23M | 187.37M | 201.86M | 214.15M | 215.54M | 208.99M | 199.93M | 198.04M | 210.03M | 207.24M | 198.74M |
Income Tax Expense | -370K | 294K | 573K | 139K | 71K | 317K | 452K | 684K | -79K | -1.99M | -2.83M | -3.71M | -4.42M | -3.33M | -4.42M | -2.62M | -1.44M | -2.07M |
Shares Outstanding (Basic) | 379.37M | 378.23M | 374.54M | 371.54M | 372.33M | 294.13M | 79.73M | 79.15M | 78.67M | 79.08M | 79.43M | 78.9M | 77.49M | 77.03M | 76.65M | 76.3M | 74.53M | 74.71M |
Shares Outstanding (Diluted) | 379.37M | 378.23M | 374.54M | 371.54M | 372.33M | 294.13M | 79.73M | 79.15M | 78.67M | 79.08M | 79.43M | 78.9M | 77.82M | 77.03M | 76.65M | 76.3M | 75.45M | 74.71M |
EPS (Basic) | -0.32 | -0.35 | -0.55 | -0.71 | -0.91 | -1.01 | -0.95 | -0.96 | -1.06 | -1.66 | -2.44 | -2.3 | -2.11 | -1.52 | -0.78 | -0.9 | -0.8 | -0.75 |
EPS (Diluted) | -0.32 | -0.35 | -0.55 | -0.71 | -0.91 | -1.01 | -0.95 | -0.96 | -1.06 | -1.66 | -2.44 | -2.3 | -2.11 | -1.52 | -0.78 | -0.9 | -0.8 | -0.75 |
EBITDA | -91.35M | -116.89M | -121.72M | -106.8M | -99.31M | -69.49M | -54.46M | -55.49M | -65.24M | -113.51M | -173.57M | -162.78M | -147.6M | -100.09M | -43.92M | -50.74M | -41.82M | -38.44M |
EBIT | -104.91M | -122.44M | -128.81M | -113.85M | -106.92M | -86.3M | -69.19M | -69.93M | -79.3M | -128.21M | -188.6M | -178.18M | -163.39M | -116.06M | -59.84M | -66.81M | -57.88M | -54.37M |
Depreciation & Amortization | 13.56M | 15.41M | 16.43M | 16.39M | 16.94M | 16.71M | 15.18M | 14.89M | 14.51M | 14.72M | 15.03M | 15.41M | 15.79M | 15.97M | 16.07M | 16.07M | 16.05M | 15.93M |